Amgen Confirms Launch Of First US Eculizumab Rival

Debuts Bkemv Interchangeable Biosimilar To Soliris

 
• By Dave Wallace
  
Amgen has launched its Soliris biosimilar in the US (Shutterstock)

More from Biosimilars

More from Business